查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423609

到 2030 年生殖毒理学测试市场预测：按产品、方法、技术、最终用户和地区分類的全球分析

Reproductive Toxicity Testing Market Forecasts to 2030 - Global Analysis By Product (Consumables, Assays and Equipment), Method (Cellular Assays, In-Silico Models, Biochemical Assays and Ex-Vivo Models), Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球生殖毒性检测市场规模为 118 亿美元，预计在预测期内复合年增长率为 11.4%，到 2030 年将达到 251.4 亿美元。

生殖毒性测试涉及评估各种物质对人类和动物生殖器官的潜在不利影响。采用多种调查方法来评估生殖毒性，包括体内（动物研究）、体外测定、计算模型和高通量筛检。评估包括评估生育力、胚胎发育、致畸性、致突变性和荷尔蒙失调等终点，提供关键资料来指南风险评估和监管决策。

根据 ClinicalTrials.gov 统计，截至 2020 年 8 月，资料库中总合281,305 项试验註册。

检验技术的进步

持续不断的技术创新，例如高通量筛检、先进的体外测定和预测计算模型正在彻底改变毒性测试领域。这些进步使得测试更加准确、高效且具有成本效益，可以对生殖毒性进行全面评估，同时减少对动物研究的依赖。此外，开发更灵敏和特异性的测试方法将更能预测人类对物质的反应，加速药物开发和产品安全评估的决策。因此，它们越来越多地被化学、製药和消费品行业采用，推动了市场扩张。

成本和时间问题

全面的生殖毒性测试需要大量的成本和较长的研究週期，特别是对于长期评估和法规遵循。资源和时间的投资可能令人望而却步，特别是对于小型公司和研究机构来说，影响了他们进行大规模试验的能力。财务负担和漫长的时间表可能会阻碍这些测试的广泛普及，限制获得全面的生殖毒性评估，并影响产品开发和监管核准流程的步伐。

扩大医药化工产业

製药和化学产业的持续成长导致新药、化学品和消费品的开发增加。需要进行全面的生殖毒性测试，以确保这些产品在进入市场之前的安全性和法规合规性。对彻底安全评估的需求不断增长，为测试服务提供者提供可靠、高效的测试服务提供了机会。此外，满足不断扩大的行业需求正在推动生殖毒性测试市场的成长，并满足药品和化学品安全评估的需求，确保为消费者提供更安全的产品。

监管障碍

多样化且严格的区域监管标准给实验室和服务供应商带来了挑战。不同的合规性要求使统一测试通讯协定的建立变得复杂，并可能延迟产品核准和市场进入。谈判这些不同的法律规范会带来复杂性，并影响生殖毒性测试服务的效率和可及性。

COVID-19 的影响

由于供应链中断、实验室关闭和研究重点的变化，COVID-19 爆发对生殖毒性测试市场产生了负面影响。这些因素使得生殖毒性测试变得更加困难和耗时。这种最初的影响反映了生物技术和製药业在疫情期间遇到的更大困难。然而，随着时间的推移和世界适应大流行的挑战，市场表现出稳健性并持续扩张。

细胞培养技术领域预计将成为预测期内最大的市场

预计细胞培养技术领域将占据最大份额。细胞培养技术可以透过观察细胞对化合物和药物的反应来评估毒性、遗传毒性和其他生殖终点。基于细胞培养的检测提供了生殖毒性的宝贵见解，并有助于药物开发、安全评估和法规遵循。此外，细胞培养技术的进步提高了准确性、效率和预测能力，塑造了生殖毒性测试方法的格局，并为该细分市场的成长做出了重大贡献。

製药和生物技术公司领域预计在预测期内复合年增长率最高

预计製药和生物技术公司部门在预测期内将出现良好成长。製药和生物技术公司广泛利用生殖毒性测试来评估对生殖健康的潜在不利影响。此类测试可确保符合监管标准，增强药物的安全性，并支持药物开发阶段的明智决策。此外，这些公司在推动对全面和专业的生殖毒性测试服务的需求和塑造市场方面发挥着重要作用，同时优先考虑其产品对全球消费者的安全性和有效性。

比最大的地区

由于严格的法律规范、不断提高的生殖健康意识以及检测方法的技术进步，亚太地区在预测期内占据了最大的市场占有率。此外，合作研究的增加和对药物安全评估的日益关注也进一步刺激了市场需求。亚太地区製药业的发展和政府的支持措施使该地区成为生殖毒性检测服务的中心，竞争的加剧和技术创新塑造了行业形势。

复合年增长率最高的地区：

由于严格的法律规范和对药品安全的日益关注，预计北美在预测期内将实现盈利增长。该地区（尤其是美国和加拿大）强劲的製药和生物技术产业正在推动对生殖毒性测试服务的需求。此外，研究机构和产业参与者之间的合作研究进一步促进了测试方法的进步，使北美成为生殖毒性测试服务和製药业创新的关键中心。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球生殖毒理学测试市场：按产品

  • 消耗品
  • 化验
    • 细菌毒性测定
    • 细菌毒性测定
    • 受体结合测定
    • 基于细胞的 ELISA 和蛋白质印迹
    • 组织培养测定
  • 装置

第六章全球生殖毒理学测试市场：依方法

  • 细胞测定
  • In Silico模型
  • 生化测定
  • 体外模型

第七章全球生殖毒理学测试市场：依技术分类

  • 细胞培养技术
  • 毒理基因组学
  • 高通量技术

第八章全球生殖毒理学测试市场：依最终用户分类

  • 学术研究所
  • 受託研究机构
  • 製药和生物技术公司
  • 其他最终用户

第九章全球生殖毒理学测试市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Thermo Fisher Scientific
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories International
  • Eurofins Scientific
  • Syngene International Limited
  • Jubilant Life Sciences Limited
  • Gentronix Ltd
  • Creative Bioarray
  • Inotiv Inc
  • MB Research Laboratories
  • Catalent, Inc.
  • Bio-Rad Laboratories
  • Evotec
  • QIAGEN
  • Promega Corporation
Product Code: SMRC24843

According to Stratistics MRC, the Global Reproductive Toxicity Testing Market is accounted for $11.80 billion in 2023 and is expected to reach $25.14 billion by 2030 growing at a CAGR of 11.4% during the forecast period. Reproductive toxicity testing involves assessing the potential adverse effects of various substances on the reproductive systems of humans or animals. Various testing methodologies, including in vivo (animal testing), in vitro assays, computational models, and high-throughput screening, are employed to assess reproductive toxicity. The assessments encompass evaluating endpoints such as fertility, embryonic development, teratogenicity, mutagenicity, and hormonal disruptions, providing essential data to guide risk assessment and regulatory decisions.

According to the ClinicalTrials.gov, a total of 281,305 studies are registered on their database as of August 2020.

Market Dynamics:

Driver:

Advancements in testing technologies

Ongoing innovations, such as high-throughput screening, sophisticated in vitro assays, and predictive computational models, revolutionise the field of toxicity testing. These advancements enhance testing accuracy, efficiency, and cost-effectiveness, allowing for comprehensive evaluation of reproductive toxicity with reduced reliance on animal testing. Furthermore, the development of more sensitive and specific testing methods enables better prediction of human responses to substances, expediting decision-making in drug development and product safety assessments. Consequently, the chemical, pharmaceutical, and consumer goods industries will employ it more frequently, driving market expansion.

Restraint:

Cost and time intensiveness

Conducting comprehensive reproductive toxicity studies involves substantial expenses and lengthy testing periods, especially for long-term assessments and regulatory compliance. The investment of resources and time can be prohibitive, particularly for smaller companies or research institutions, impacting their ability to conduct extensive testing. The financial burden and extended timelines hinder widespread adoption of these tests, potentially limiting access to comprehensive reproductive toxicity evaluations and affecting the pace of product development and regulatory approval processes.

Opportunity:

Expanding Pharmaceutical and Chemical Industries

With continuous growth in the pharmaceutical and chemical sectors, there's been an increased development of new drugs, chemicals, and consumer products. Ensuring the safety and regulatory compliance of these products before market entry necessitates comprehensive reproductive toxicity testing. This rising demand for thorough safety assessments presents an opportunity for testing service providers to offer reliable and efficient testing services. Moreover, addressing the needs of expanding industries fuels the growth of the reproductive toxicity testing market, catering to the demand for safety evaluations in pharmaceuticals and chemicals, thus ensuring safer products for consumers.

Threat:

Regulatory hurdles

Diverse and stringent regulatory standards across regions pose challenges for testing laboratories and service providers. Varying compliance demands complicate the establishment of uniform testing protocols, potentially delaying product approvals and market entry. Negotiating these diverse regulatory frameworks creates complexity, impacting the efficiency and accessibility of reproductive toxicity testing services.

Covid-19 Impact

The COVID-19 pandemic had a detrimental impact on the market for reproductive toxicity testing due to supply chain disruptions, laboratory closures, and a change in research priorities. These factors made reproductive toxicity testing more difficult and time-consuming to perform. This initial effect was a reflection of the larger difficulties that the biotechnology and pharmaceutical sectors experienced during the epidemic. However, the market demonstrated robustness and sustained expansion as time passed and the world adjusted to the pandemic's challenges.

The cell culture technology segment is expected to be the largest during the forecast period

The cell culture technology segment is estimated to hold the largest share. Cell culture technology allows for the evaluation of toxicity, genotoxicity, and other reproductive endpoints by observing cellular responses to chemical compounds or pharmaceuticals. Cell culture-based assays provide valuable insights into reproductive toxicity, aiding in drug development, safety assessment, and regulatory compliance. Moreover, advancements in cell culture techniques enhance accuracy, efficiency, and predictive capabilities, shaping the landscape of reproductive toxicity testing methodologies and contributing significantly to this market segment's growth.

The pharmaceutical and biotechnology companies segment is expected to have the highest CAGR during the forecast period

The pharmaceutical and biotechnology companies segment is anticipated to have lucrative growth during the forecast period. Pharmaceutical and biotechnology companies extensively utilise reproductive toxicity testing to assess potential adverse effects on reproductive health. Such testing ensures compliance with regulatory standards, enhances drug safety profiles, and aids in making informed decisions during drug development stages. Moreover, these companies drive the demand for comprehensive and specialised reproductive toxicity testing services, playing a critical role in shaping the market while prioritising the safety and efficacy of their products for global consumers.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to its stringent regulatory frameworks, rising awareness of reproductive health, and technological advancements in testing methodologies. Furthermore, growing research collaborations and a burgeoning focus on drug safety assessment further propel market demand. The region's evolving pharmaceutical industry, coupled with supportive government initiatives, positions the Asia-Pacific as a hub for reproductive toxicity testing services, with heightened competition and innovation shaping its landscape.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, due to stringent regulatory frameworks and a heightened focus on pharmaceutical safety. The region's robust pharmaceutical and biotechnology industries, particularly in the United States and Canada, drive the demand for reproductive toxicity testing services. Furthermore, collaborations between research institutions and industry players further contribute to advancements in testing methodologies, positioning North America as a pivotal hub for reproductive toxicity testing services and innovations in the pharmaceutical sector.

Key players in the market

Some of the key players in the Reproductive Toxicity Testing Market include Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Charles River Laboratories International, Eurofins Scientific, Syngene International Limited, Jubilant Life Sciences Limited, Gentronix Ltd, Creative Bioarray, Inotiv Inc, MB Research Laboratories, Catalent, Inc., Bio-Rad Laboratories, Evotec, QIAGEN and Promega Corporation.

Key Developments:

In May 2023, Wheeler Bio, a CDMO, collaborated with Charles River Labs to utilize RightSource, a flexible biologic testing lab, at its Oklahoma City facility. This partnership aimed to enhance Wheeler Bio's quality control without the need to establish its own lab, ultimately benefiting its biologic products and potential clients.

In October 2022, Thermo Fisher Scientific Inc. declared that it had expanded its laboratory operations in Highland Heights, Kentucky, to assist customers in delivering personalized medications to patients. The existing facility, which included central laboratory and biomarker operations, provided biopharma customers with high-quality laboratory services to accelerate drug development. This move increased the company's clinical diagnostics business worldwide and enhanced its global presence across the business space.

Products Covered:

  • Consumables
  • Assays
  • Equipment

Methods Covered:

  • Cellular Assays
  • In-Silico Models
  • Biochemical Assays
  • Ex-Vivo Models

Technologies Covered:

  • Cell Culture Technology
  • Toxicogenomics
  • High-Throughput Technology

End Users Covered:

  • Academic and Research Institutes
  • Contract Research Organizations
  • Pharmaceutical and Biotechnology Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Reproductive Toxicity Testing Market, By Product

  • 5.1 Introduction
  • 5.2 Consumables
  • 5.3 Assays
    • 5.3.1 Bacterial Toxicity Assays
    • 5.3.2 Bacterial Toxicity Assays
    • 5.3.3 Receptor-Binding Assays
    • 5.3.4 Cell-Based ELISA & Western Blot
    • 5.3.5 Tissue Culture Assays
  • 5.4 Equipment

6 Global Reproductive Toxicity Testing Market, By Method

  • 6.1 Introduction
  • 6.2 Cellular Assays
  • 6.3 In-Silico Models
  • 6.4 Biochemical Assays
  • 6.5 Ex-Vivo Models

7 Global Reproductive Toxicity Testing Market, By Technology

  • 7.1 Introduction
  • 7.2 Cell Culture Technology
  • 7.3 Toxicogenomics
  • 7.4 High-Throughput Technology

8 Global Reproductive Toxicity Testing Market, By End User

  • 8.1 Introduction
  • 8.2 Academic and Research Institutes
  • 8.3 Contract Research Organizations
  • 8.4 Pharmaceutical and Biotechnology Companies
  • 8.5 Other End Users

9 Global Reproductive Toxicity Testing Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Thermo Fisher Scientific
  • 11.2 Laboratory Corporation of America Holdings
  • 11.3 Charles River Laboratories International
  • 11.4 Eurofins Scientific
  • 11.5 Syngene International Limited
  • 11.6 Jubilant Life Sciences Limited
  • 11.7 Gentronix Ltd
  • 11.8 Creative Bioarray
  • 11.9 Inotiv Inc
  • 11.10 MB Research Laboratories
  • 11.11 Catalent, Inc.
  • 11.12 Bio-Rad Laboratories
  • 11.13 Evotec
  • 11.14 QIAGEN
  • 11.15 Promega Corporation

List of Tables

  • Table 1 Global Reproductive Toxicity Testing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Reproductive Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Reproductive Toxicity Testing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 4 Global Reproductive Toxicity Testing Market Outlook, By Assays (2021-2030) ($MN)
  • Table 5 Global Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 6 Global Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 7 Global Reproductive Toxicity Testing Market Outlook, By Receptor-Binding Assays (2021-2030) ($MN)
  • Table 8 Global Reproductive Toxicity Testing Market Outlook, By Cell-Based ELISA & Western Blot (2021-2030) ($MN)
  • Table 9 Global Reproductive Toxicity Testing Market Outlook, By Tissue Culture Assays (2021-2030) ($MN)
  • Table 10 Global Reproductive Toxicity Testing Market Outlook, By Equipment (2021-2030) ($MN)
  • Table 11 Global Reproductive Toxicity Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 12 Global Reproductive Toxicity Testing Market Outlook, By Cellular Assays (2021-2030) ($MN)
  • Table 13 Global Reproductive Toxicity Testing Market Outlook, By In-Silico Models (2021-2030) ($MN)
  • Table 14 Global Reproductive Toxicity Testing Market Outlook, By Biochemical Assays (2021-2030) ($MN)
  • Table 15 Global Reproductive Toxicity Testing Market Outlook, By Ex-Vivo Models (2021-2030) ($MN)
  • Table 16 Global Reproductive Toxicity Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 17 Global Reproductive Toxicity Testing Market Outlook, By Cell Culture Technology (2021-2030) ($MN)
  • Table 18 Global Reproductive Toxicity Testing Market Outlook, By Toxicogenomics (2021-2030) ($MN)
  • Table 19 Global Reproductive Toxicity Testing Market Outlook, By High-Throughput Technology (2021-2030) ($MN)
  • Table 20 Global Reproductive Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 21 Global Reproductive Toxicity Testing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 22 Global Reproductive Toxicity Testing Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 23 Global Reproductive Toxicity Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 24 Global Reproductive Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 North America Reproductive Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Reproductive Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 27 North America Reproductive Toxicity Testing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 28 North America Reproductive Toxicity Testing Market Outlook, By Assays (2021-2030) ($MN)
  • Table 29 North America Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 30 North America Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 31 North America Reproductive Toxicity Testing Market Outlook, By Receptor-Binding Assays (2021-2030) ($MN)
  • Table 32 North America Reproductive Toxicity Testing Market Outlook, By Cell-Based ELISA & Western Blot (2021-2030) ($MN)
  • Table 33 North America Reproductive Toxicity Testing Market Outlook, By Tissue Culture Assays (2021-2030) ($MN)
  • Table 34 North America Reproductive Toxicity Testing Market Outlook, By Equipment (2021-2030) ($MN)
  • Table 35 North America Reproductive Toxicity Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 36 North America Reproductive Toxicity Testing Market Outlook, By Cellular Assays (2021-2030) ($MN)
  • Table 37 North America Reproductive Toxicity Testing Market Outlook, By In-Silico Models (2021-2030) ($MN)
  • Table 38 North America Reproductive Toxicity Testing Market Outlook, By Biochemical Assays (2021-2030) ($MN)
  • Table 39 North America Reproductive Toxicity Testing Market Outlook, By Ex-Vivo Models (2021-2030) ($MN)
  • Table 40 North America Reproductive Toxicity Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 41 North America Reproductive Toxicity Testing Market Outlook, By Cell Culture Technology (2021-2030) ($MN)
  • Table 42 North America Reproductive Toxicity Testing Market Outlook, By Toxicogenomics (2021-2030) ($MN)
  • Table 43 North America Reproductive Toxicity Testing Market Outlook, By High-Throughput Technology (2021-2030) ($MN)
  • Table 44 North America Reproductive Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 45 North America Reproductive Toxicity Testing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 46 North America Reproductive Toxicity Testing Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 47 North America Reproductive Toxicity Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 48 North America Reproductive Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 Europe Reproductive Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Reproductive Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 51 Europe Reproductive Toxicity Testing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 52 Europe Reproductive Toxicity Testing Market Outlook, By Assays (2021-2030) ($MN)
  • Table 53 Europe Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 54 Europe Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 55 Europe Reproductive Toxicity Testing Market Outlook, By Receptor-Binding Assays (2021-2030) ($MN)
  • Table 56 Europe Reproductive Toxicity Testing Market Outlook, By Cell-Based ELISA & Western Blot (2021-2030) ($MN)
  • Table 57 Europe Reproductive Toxicity Testing Market Outlook, By Tissue Culture Assays (2021-2030) ($MN)
  • Table 58 Europe Reproductive Toxicity Testing Market Outlook, By Equipment (2021-2030) ($MN)
  • Table 59 Europe Reproductive Toxicity Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 60 Europe Reproductive Toxicity Testing Market Outlook, By Cellular Assays (2021-2030) ($MN)
  • Table 61 Europe Reproductive Toxicity Testing Market Outlook, By In-Silico Models (2021-2030) ($MN)
  • Table 62 Europe Reproductive Toxicity Testing Market Outlook, By Biochemical Assays (2021-2030) ($MN)
  • Table 63 Europe Reproductive Toxicity Testing Market Outlook, By Ex-Vivo Models (2021-2030) ($MN)
  • Table 64 Europe Reproductive Toxicity Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 65 Europe Reproductive Toxicity Testing Market Outlook, By Cell Culture Technology (2021-2030) ($MN)
  • Table 66 Europe Reproductive Toxicity Testing Market Outlook, By Toxicogenomics (2021-2030) ($MN)
  • Table 67 Europe Reproductive Toxicity Testing Market Outlook, By High-Throughput Technology (2021-2030) ($MN)
  • Table 68 Europe Reproductive Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 69 Europe Reproductive Toxicity Testing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 70 Europe Reproductive Toxicity Testing Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 71 Europe Reproductive Toxicity Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 72 Europe Reproductive Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 75 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 76 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Assays (2021-2030) ($MN)
  • Table 77 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 78 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 79 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Receptor-Binding Assays (2021-2030) ($MN)
  • Table 80 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Cell-Based ELISA & Western Blot (2021-2030) ($MN)
  • Table 81 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Tissue Culture Assays (2021-2030) ($MN)
  • Table 82 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Equipment (2021-2030) ($MN)
  • Table 83 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 84 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Cellular Assays (2021-2030) ($MN)
  • Table 85 Asia Pacific Reproductive Toxicity Testing Market Outlook, By In-Silico Models (2021-2030) ($MN)
  • Table 86 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Biochemical Assays (2021-2030) ($MN)
  • Table 87 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Ex-Vivo Models (2021-2030) ($MN)
  • Table 88 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 89 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Cell Culture Technology (2021-2030) ($MN)
  • Table 90 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Toxicogenomics (2021-2030) ($MN)
  • Table 91 Asia Pacific Reproductive Toxicity Testing Market Outlook, By High-Throughput Technology (2021-2030) ($MN)
  • Table 92 Asia Pacific Reproductive Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 93 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 94 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 95 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 96 Asia Pacific Reproductive Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 97 South America Reproductive Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Reproductive Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 99 South America Reproductive Toxicity Testing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 100 South America Reproductive Toxicity Testing Market Outlook, By Assays (2021-2030) ($MN)
  • Table 101 South America Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 102 South America Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 103 South America Reproductive Toxicity Testing Market Outlook, By Receptor-Binding Assays (2021-2030) ($MN)
  • Table 104 South America Reproductive Toxicity Testing Market Outlook, By Cell-Based ELISA & Western Blot (2021-2030) ($MN)
  • Table 105 South America Reproductive Toxicity Testing Market Outlook, By Tissue Culture Assays (2021-2030) ($MN)
  • Table 106 South America Reproductive Toxicity Testing Market Outlook, By Equipment (2021-2030) ($MN)
  • Table 107 South America Reproductive Toxicity Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 108 South America Reproductive Toxicity Testing Market Outlook, By Cellular Assays (2021-2030) ($MN)
  • Table 109 South America Reproductive Toxicity Testing Market Outlook, By In-Silico Models (2021-2030) ($MN)
  • Table 110 South America Reproductive Toxicity Testing Market Outlook, By Biochemical Assays (2021-2030) ($MN)
  • Table 111 South America Reproductive Toxicity Testing Market Outlook, By Ex-Vivo Models (2021-2030) ($MN)
  • Table 112 South America Reproductive Toxicity Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 113 South America Reproductive Toxicity Testing Market Outlook, By Cell Culture Technology (2021-2030) ($MN)
  • Table 114 South America Reproductive Toxicity Testing Market Outlook, By Toxicogenomics (2021-2030) ($MN)
  • Table 115 South America Reproductive Toxicity Testing Market Outlook, By High-Throughput Technology (2021-2030) ($MN)
  • Table 116 South America Reproductive Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 117 South America Reproductive Toxicity Testing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 118 South America Reproductive Toxicity Testing Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 119 South America Reproductive Toxicity Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 120 South America Reproductive Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 121 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 123 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 124 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Assays (2021-2030) ($MN)
  • Table 125 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 126 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Bacterial Toxicity Assays (2021-2030) ($MN)
  • Table 127 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Receptor-Binding Assays (2021-2030) ($MN)
  • Table 128 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Cell-Based ELISA & Western Blot (2021-2030) ($MN)
  • Table 129 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Tissue Culture Assays (2021-2030) ($MN)
  • Table 130 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Equipment (2021-2030) ($MN)
  • Table 131 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 132 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Cellular Assays (2021-2030) ($MN)
  • Table 133 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By In-Silico Models (2021-2030) ($MN)
  • Table 134 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Biochemical Assays (2021-2030) ($MN)
  • Table 135 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Ex-Vivo Models (2021-2030) ($MN)
  • Table 136 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 137 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Cell Culture Technology (2021-2030) ($MN)
  • Table 138 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Toxicogenomics (2021-2030) ($MN)
  • Table 139 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By High-Throughput Technology (2021-2030) ($MN)
  • Table 140 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 141 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
  • Table 142 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 143 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 144 Middle East & Africa Reproductive Toxicity Testing Market Outlook, By Other End Users (2021-2030) ($MN)